Statement by the Board of Directors of Swedish Orphan Biovitrum AB in relation to the public cash offer by Advent and GIC

This statement is made by the Board of Directors of Swedish Orphan Biovitrum AB (publ) pursuant to Section II.19 of Nasdaq Stockholm’s Takeover Rules . Advent International Corporation and Aurora Investment Pte Ltd an affiliate of GIC Pte Ltd through Agnafit Bidco AB have announced a public cash offer to Sobi’s shareholders to transfer their shares in Sobi to Agnafit Bidco . Under the terms of the Offer, Agnafit Bidco is offering SEK 235 per Sobi share in cash , which values the issued share capital of Sobi at approximately SEK 69.4 billion.Having concluded this assessment, the Board believes that the terms of the Offer recognise Sobi’s long-term growth prospects, as well as the risks associated with those prospects, and provides certainty, in cash, to the Sobi shareholders.